Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Price Performance
The firm has a 50 day moving average price of C$2.00 and a two-hundred day moving average price of C$2.00. The company has a market cap of C$21.54 million and a P/E ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
See Also
- Five stocks we like better than Liberty Biopharma
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- How to Invest in Insurance Companies: A Guide
- AppLovin: Can Record Profits Overcome Market Skepticism?
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 04/14 – 04/18
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
